Accessibility Menu
Hlk Biotech Group logo

Hlk Biotech Group(OTC) AMHD

Market Cap$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)-100%
5 Year-99%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Hlk Biotech Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-07
Hlk Biotech Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-28
1 month+0%USD 0.002026-07-08
3 month+0%USD 0.002026-05-08
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-07-31
3 year+100%USD 0.002023-07-24
5 year-99.33%USD 0.032021-08-06
Since inception-100%USD 28,127,812.781999-02-11

Hlk Biotech Group Financials at a Glance

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

AMHD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hlk Biotech Group

HLK Biotech Holding Group, Inc. is a company focused on the production and distribution of biodiesel, alongside engaging in real estate asset acquisition. Formerly known as Amelot Holdings, Inc., the company rebranded in February 2018 and operates primarily through its subsidiaries.

Products and Services
  • Production and distribution of biodiesel
  • Acquisition and management of real estate assets
  • Engagement in energy sector activities
Growth Outlook
  • Focus on expanding biodiesel production capabilities
  • Strategic acquisitions in the real estate sector planned
  • Potential for increased market demand for renewable energy solutions
Financial Highlights
  • Market capitalization stands at approximately $925 million
  • Recent trading volume averaged 2,500 shares
  • Stock price has remained stable at $0.0002
HLK Biotech Holding Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, with a focus on sustainable energy solutions. The company's commitment to biodiesel production aligns with the growing demand for renewable energy, positioning it favorably in the market. The strategic direction towards real estate acquisition further diversifies its portfolio, potentially enhancing revenue streams. With a stable stock price and a solid market capitalization, HLK Biotech presents an intriguing opportunity for investors interested in the intersection of biotechnology and renewable energy.
AI Generated • Aug 14, 2026

Industry

Oil, Gas and Consumable Fuels

Sector

Energy

Headquarters

Norfolk, VA 23517, US

AMHD Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.77M

Volume

500

Avg. Volume

11.571

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Hlk Biotech Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$1.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MMTCMicro Imaging Technology, Inc.
$0.00+0.00%
UTRSMinerva Surgical, Inc.
$0.00+0.00%
CNNXFCannAmerica Brands Corp.
$0.00+0.00%
CALACalithera Biosciences, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.81+0.06%
SPCXSpace Exploration Technologies
$134.00-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.88-0.03%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About AMHD

What is the current price of Hlk Biotech Group?

Hlk Biotech Group is trading at $0.00 per share.

What is the 52-week range for Hlk Biotech Group?

Over the past 52 weeks, Hlk Biotech Group has traded between $0.00 and $0.00.

How much debt does Hlk Biotech Group have?

Hlk Biotech Group total debt is unavailable.

How much cash does Hlk Biotech Group have on hand?

Hlk Biotech Group does not have cash on hand data available.

What is Hlk Biotech Group’s dividend yield?

Hlk Biotech Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.